Biocon Biologics, a wholly-owned subsidiary of Biocon, has partnered with US-based Adagio Therapeutics for an exclusive licence to manufacture and commercialise an antibody treatment based on ADG20 ...
Biocon Biologics announced that the US-based Adagio Therapeutics has granted an exclusive license to Biocon Biologics to manufacture and commercialise an antibody treatment based on ADG20 for India ...
New Delhi: Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has said US-based Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback